Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03ZZH
|
|||
Former ID |
DCL000989
|
|||
Drug Name |
SLV-313
|
|||
Synonyms |
L001624
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Discontinued in Phase 1 | [1] | |
Company |
Solvay Pharma
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H24FN3O2
|
|||
Canonical SMILES |
C1CN(CCN1CC2=CC(=CN=C2)C3=CC=C(C=C3)F)C4=C5C(=CC=C4)OCCO5
|
|||
InChI |
1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2
|
|||
InChIKey |
IUVSEUFHPNITEQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 222551-17-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
REF 2 | Synthesis and dual D2 and 5-HT1A receptor binding affinities of 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones. Med Chem. 2014;10(5):484-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.